Patent 9155290 was granted and assigned to Regeneron Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.
Genetically modified non-human animals comprising a humanized interleukin-15 (IL-15) gene. Cells, embryos, and non-human animals comprising a human IL-15 gene. Rodents that express humanized or human IL-15 protein.